- Home
- TNGX vs DH Comparison
TNGX vs DH Comparison
Compare TNGX & DH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- DH
- Stock Information
- Founded
- TNGX 2014
- DH 2011
- Country
- TNGX United States
- DH United States
- Employees
- TNGX N/A
- DH N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- DH Computer Software: Prepackaged Software
- Sector
- TNGX Health Care
- DH Technology
- Exchange
- TNGX Nasdaq
- DH Nasdaq
- Market Cap
- TNGX 351.2M
- DH 280.0M
- IPO Year
- TNGX N/A
- DH 2021
- Fundamental
- Price
- TNGX $5.87
- DH $4.16
- Analyst Decision
- TNGX Strong Buy
- DH Hold
- Analyst Count
- TNGX 6
- DH 10
- Target Price
- TNGX $12.20
- DH $5.10
- AVG Volume (30 Days)
- TNGX 2.9M
- DH 769.5K
- Earning Date
- TNGX 08-06-2025
- DH 08-04-2025
- Dividend Yield
- TNGX N/A
- DH N/A
- EPS Growth
- TNGX N/A
- DH N/A
- EPS
- TNGX N/A
- DH N/A
- Revenue
- TNGX $40,990,000.00
- DH $247,913,000.00
- Revenue This Year
- TNGX N/A
- DH N/A
- Revenue Next Year
- TNGX N/A
- DH $1.66
- P/E Ratio
- TNGX N/A
- DH N/A
- Revenue Growth
- TNGX 10.09
- DH N/A
- 52 Week Low
- TNGX $1.03
- DH $2.15
- 52 Week High
- TNGX $12.02
- DH $6.17
- Technical
- Relative Strength Index (RSI)
- TNGX 74.27
- DH 70.72
- Support Level
- TNGX $5.34
- DH $3.96
- Resistance Level
- TNGX $5.63
- DH $4.23
- Average True Range (ATR)
- TNGX 0.50
- DH 0.16
- MACD
- TNGX -0.04
- DH 0.01
- Stochastic Oscillator
- TNGX 84.15
- DH 86.27
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About DH Definitive Healthcare Corp.
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.